RenaissanceRe Holdings Ltd.
RNRRenaissanceRe Holdings Ltd. is a global provider of reinsurance and insurance solutions, specializing in property, casualty, and specialty lines. Founded in 1993, the company focuses on offering underwriting expertise and innovative risk management strategies to support its clients' needs across various markets worldwide.
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| June 30, 2026 | $0.41 | 2026-06-15 | 2026-06-15 |
| March 31, 2026 | $0.41 | 2026-03-13 | 2026-03-13 |
| December 31, 2025 | $0.40 | 2025-12-15 | 2025-12-15 |
| September 30, 2025 | $0.40 | 2025-09-15 | 2025-09-15 |
| June 30, 2025 | $0.40 | 2025-06-13 | 2025-06-13 |
Dividends Summary
- Consistent Payer: RenaissanceRe Holdings Ltd. has rewarded shareholders with 91 dividend payments over the past 23 years.
- Total Returned Value: Investors who held RNR shares during this period received a total of $26.93 per share in dividend income.
- Latest Payout: The most recent dividend of $0.41/share was paid 18 days ago, on June 30, 2026.
- Yield & Schedule: RNR currently pays dividends quarterly with an annual yield of 0.50%.
- Dividend Growth: Since 2003, the dividend payout has grown by 173.3%, from $0.15 to $0.41.
- Dividend Reliability: RNR has maintained or increased its dividend for 91 consecutive payments.
Company News
Axis Capital, a specialty insurer and reinsurer, delivered strong 2025 results with record premiums, record underwriting income, and a 19.4% annualized return on equity. The company's shift toward higher-margin specialty insurance lines is paying off, with the insurance segment now representing 74% of business. However, investors should be cautio...
VedTechBio, a biopharma-tech company, has launched RxAgentAI, an AI and ML platform for the life sciences industry. It has also announced a drug discovery collaboration with RenaissThera, a biotech company working on metabolic diseases.
RenaissanceRe (RNR) is expected to benefit from rising premiums, net investment income, and underwriting capabilities.
Improved pricing, expansion of international business, reserving discipline, a solid balance sheet and a prudent capital management policy should help W.R. Berkley (WRB) maintain its streak of dividend hikes and special dividends.
